Size | Price | Stock | Qty |
---|---|---|---|
10mg |
|
||
50mg |
|
||
100mg |
|
||
250mg |
|
||
500mg |
|
||
Other Sizes |
|
ln Vitro |
(-)-Epicatechin has an IC50 of 3.2 μM and >95% inhibitory action against cyclooxygenase-1 (COX-1) at 70 μg/mL [1]. (-)-Epicatechin NF-blocks the nuclear localization of the κB p65 subunit, which prevents IL-1β-induced iNOS production. It has been demonstrated that the addition of IL-1β causes (-)-epicatechin to burst and limit insulin release in RINm5F cells. Furthermore, it was proven that (-)-epicatechin was swellable. It increases the capacity of (-)-epicatechin to prevent NF-κB from binding to DNA in these cells by suppressing the growth of Jurkat T cells and Hodgkin's positioning cells. Combining 20 μM Panaxadiol with 150, 200, or 250 μM (-)-Epicatechin inhibited proliferation in human rectal cancer HCT-116 cells by 51%, 97%, and 95%, respectively. The swapped cell fluorescence levels increased by 11.9%, 16.6%, and 25.8%, as shown by Annexin V/PI staining [2].
|
---|---|
ln Vivo |
The animals were given water (vehicle) or 1 mg/kg of (-)-epicatechin via wall gavage twice a day. Over the course of 15 days, the exercise group used a treadmill. Utilizing (-)-epicatechin can boost fatigue resistance during in situ visits by around 30% and improve treadmill performance by approximately 50% [3].
|
References |
[1]. Waffo-Téguo P, et al. Potential cancer-chemopreventive activities of wine stilbenoids and flavans extracted from grape (Vitis vinifera) cell cultures. Nutr Cancer. 2001;40(2):173-9.
[2]. Shay J, et al. Molecular Mechanisms and Therapeutic Effects of (-)-Epicatechin and Other Polyphenols in Cancer, Inflammation, Diabetes, and Neurodegeneration. Oxid Med Cell Longev. 2015;2015:181260. [3]. Nogueira L, et al. (-)-Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle. J Physiol. 2011 Sep 15;589(Pt 18):4615-31 |
Molecular Formula |
C15H14O6
|
---|---|
Molecular Weight |
290.27
|
CAS # |
490-46-0
|
Related CAS # |
(-)-Epicatechin gallate;1257-08-5;(+)-Epicatechin;35323-91-2;(±)-Epicatechin-13C3;1217780-28-3
|
Appearance |
Typically exists as solids (or liquids in special cases) at room temperature
|
SMILES |
O1C2=C([H])C(=C([H])C(=C2C([H])([H])[C@]([H])([C@@]1([H])C1C([H])=C([H])C(=C(C=1[H])O[H])O[H])O[H])O[H])O[H]
|
Synonyms |
epi-Catechin (-)-Epicatechin Epicatechin
|
HS Tariff Code |
2934.99.9001
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
DMSO : ~100 mg/mL (~344.51 mM)
H2O : ~2 mg/mL (~6.89 mM) |
---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (8.61 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (8.61 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: ≥ 2.5 mg/mL (8.61 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 3.4451 mL | 17.2253 mL | 34.4507 mL | |
5 mM | 0.6890 mL | 3.4451 mL | 6.8901 mL | |
10 mM | 0.3445 mL | 1.7225 mL | 3.4451 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.